Prognosis and Status of Lymph Node Involvement in Patients with Adenocarcinoma in Situ and Minimally Invasive Adenocarcinoma-a Systematic Literature Review and Pooled-data Analysis

Overview

Journal J Thorac Dis

Publisher AME Publishing Company

Specialty Pulmonary Medicine

Date 2015 Dec 31

PMID 26716039

Citations 6

Authors

Long Jiang

Weiqiang Yin

Guilin Peng

Wei Wang

Jianrong Zhang

Yang Liu

Shengyi Zhong

Qihua He

Wenhua Liang

Jianxing He

Affiliations

Soon will be listed here.

Abstract

Background: Adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA) have been brought up that substitute for bronchioloalveolar carcinoma (BAC), according to the new classification of lung adenocarcinoma. There has been increasing opinions that argues for the adjustment of lymph node disposition in patients with such early stage tumors. Therefore, we sought to overview the prognosis and status of lymph node involvement in AIS/MIA patients.

Methods: PubMed, Springer and Ovid databases were searched for relevant studies. Data was extracted and results summarized to demonstrate the disposition of lymph nodes in AIS/MIA.

Results: Twenty-three studies consisting of 6,137 lung adenocarcinoma were included. AIS/MIA accounted for 821 of the total 6,137. All included patients received curative surgery. After a review of the summarized data we found that only one patient (with MIA) had N1 node metastasis, N2 disease was not found in any of the included patients. In concordance with this, studies that reported 5-year disease free survival (5-year DFS) have almost 100% rate.

Conclusions: Our findings indicated that patients with AIS/MIA have good survival prognosis after surgical resection, and that recurrence and lymph node metastasis in these patients is rare. Therefore, we strongly encouraged further studies to determine the role of different lymph node disposition strategies.

Citing Articles

Does clinical T1N0 GGN really require checking for distant metastasis during initial staging for lung cancer?.

Imai K, Kurihara N, Konno M, Mori N, Takashima S, Kuriyama S Cancer Imaging. 2024; 24(1):69.

PMID: 38831467 PMC: 11149246. DOI: 10.1186/s40644-024-00714-7.

Predicting the pathological invasiveness of early lung adenocarcinoma prior to surgery using Deauville criteria: reliability and validity.

Nishimori M, Iwasa H, Nakaji K, Nitta N, Miyatake K, Yoshimatsu R Jpn J Radiol. 2023; 41(7):768-776.

PMID: 36752955 PMC: 10313578. DOI: 10.1007/s11604-023-01397-z.

Incidence of venous thromboembolism after surgery for adenocarcinoma and the validity of the modified Caprini score: A propensity score-matched study.

Cai Y, Dong H, Li X, Ye X, Chen S, Hu B Front Oncol. 2022; 12:976988.

PMID: 36119540 PMC: 9478866. DOI: 10.3389/fonc.2022.976988.

[Computed tomography findings, clinicopathological features, genetic characteristics and prognosis of and minimally invasive lung adenocarcinomas].

Shen L, Lin J, Wang B, Xu H, Zhao K, Zhang L Nan Fang Yi Ke Da Xue Xue Bao. 2019; 39(9):1107-1112.

PMID: 31640952 PMC: 6881738. DOI: 10.12122/j.issn.1673-4254.2019.09.17.

Clinical characteristics and programmed cell death ligand-1 expression in adenocarcinoma and minimally invasive adenocarcinoma of lung.

Yu R, He Z, Lou Y, Jiang H, Wu Y, Liu Z Oncotarget. 2017; 8(58):97801-97810.

PMID: 29228652 PMC: 5716692. DOI: 10.18632/oncotarget.22082.

References

Oka S, Hanagiri T, Uramoto H, Baba T, Takenaka M, Yasuda M . Surgical resection for patients with mucinous bronchioloalveolar carcinoma. Asian J Surg. 2010; 33(2):89-93. DOI: 10.1016/S1015-9584(10)60015-2. View

Yeh Y, Nitadori J, Kadota K, Yoshizawa A, Rekhtman N, Moreira A . Using frozen section to identify histological patterns in stage I lung adenocarcinoma of ≤ 3 cm: accuracy and interobserver agreement. Histopathology. 2014; 66(7):922-38. PMC: 4536823. DOI: 10.1111/his.12468. View

Imai K, Minamiya Y, Goto A, Nanjo H, Saito H, Motoyama S . Bronchioloalveolar invasion in non-small cell lung cancer is associated with expression of transforming growth factor-β1. World J Surg Oncol. 2013; 11:113. PMC: 3664590. DOI: 10.1186/1477-7819-11-113. View

Yoshida J, Nagai K, Yokose T, Nishimura M, Kakinuma R, Ohmatsu H . Limited resection trial for pulmonary ground-glass opacity nodules: fifty-case experience. J Thorac Cardiovasc Surg. 2005; 129(5):991-6. DOI: 10.1016/j.jtcvs.2004.07.038. View

Borczuk A, Qian F, Kazeros A, Eleazar J, Assaad A, Sonett J . Invasive size is an independent predictor of survival in pulmonary adenocarcinoma. Am J Surg Pathol. 2008; 33(3):462-9. PMC: 2987634. DOI: 10.1097/PAS.0b013e318190157c. View

Koike T, Togashi K, Shirato T, Sato S, Hirahara H, Sugawara M . Limited resection for noninvasive bronchioloalveolar carcinoma diagnosed by intraoperative pathologic examination. Ann Thorac Surg. 2009; 88(4):1106-11. DOI: 10.1016/j.athoracsur.2009.06.051. View

Okada M, Sakamoto T, Yuki T, Mimura T, Miyoshi K, Tsubota N . Selective mediastinal lymphadenectomy for clinico-surgical stage I non-small cell lung cancer. Ann Thorac Surg. 2006; 81(3):1028-32. DOI: 10.1016/j.athoracsur.2005.09.078. View

Sakurai H, Maeshima A, Watanabe S, Suzuki K, Tsuchiya R, Maeshima A . Grade of stromal invasion in small adenocarcinoma of the lung: histopathological minimal invasion and prognosis. Am J Surg Pathol. 2004; 28(2):198-206. DOI: 10.1097/00000478-200402000-00007. View

Darling G, Allen M, Decker P, Ballman K, Malthaner R, Inculet R . Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030.... J Thorac Cardiovasc Surg. 2011; 141(3):662-70. PMC: 5082844. DOI: 10.1016/j.jtcvs.2010.11.008. View

10.

Anami Y, Iijima T, Suzuki K, Yokota J, Minami Y, Kobayashi H . Bronchioloalveolar carcinoma (lepidic growth) component is a more useful prognostic factor than lymph node metastasis. J Thorac Oncol. 2009; 4(8):951-8. DOI: 10.1097/JTO.0b013e3181ad8631. View

11.

Yoshizawa A, Sumiyoshi S, Sonobe M, Kobayashi M, Fujimoto M, Kawakami F . Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients. J Thorac Oncol. 2012; 8(1):52-61. DOI: 10.1097/JTO.0b013e3182769aa8. View

12.

Noguchi M, Morikawa A, Kawasaki M, Matsuno Y, Yamada T, Hirohashi S . Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer. 1995; 75(12):2844-52. DOI: 10.1002/1097-0142(19950615)75:12<2844::aid-cncr2820751209>3.0.co;2-#. View

13.

Xu L, Tavora F, Battafarano R, Burke A . Adenocarcinomas with prominent lepidic spread: retrospective review applying new classification of the American Thoracic Society. Am J Surg Pathol. 2011; 36(2):273-82. DOI: 10.1097/PAS.0b013e31823b3eeb. View

14.

Yim J, Zhu L, Chiriboga L, Watson H, Goldberg J, Moreira A . Histologic features are important prognostic indicators in early stages lung adenocarcinomas. Mod Pathol. 2006; 20(2):233-41. DOI: 10.1038/modpathol.3800734. View

15.

Zhang Y, Qiang J, Ye J, Ye X, Zhang J . High resolution CT in differentiating minimally invasive component in early lung adenocarcinoma. Lung Cancer. 2014; 84(3):236-41. DOI: 10.1016/j.lungcan.2014.02.008. View

16.

Ishiwa N, Ogawa N, Shoji A, Maehara T, Hayashi Y, Takanashi Y . Correlation between lymph node micrometastasis and histologic classification of small lung adenocarcinomas, in considering the indication of limited surgery. Lung Cancer. 2003; 39(2):159-64. DOI: 10.1016/s0169-5002(02)00442-7. View

17.

Tsuta K, Kawago M, Inoue E, Yoshida A, Takahashi F, Sakurai H . The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations. Lung Cancer. 2013; 81(3):371-376. DOI: 10.1016/j.lungcan.2013.06.012. View

18.

Jiang W, Chen X, Xi J, Wang Q . Selective mediastinal lymphadenectomy without intraoperative frozen section examinations for clinical stage I non-small-cell lung cancer: retrospective study of 403 cases. World J Surg. 2012; 37(2):392-7. DOI: 10.1007/s00268-012-1849-9. View

19.

Yanagawa N, Shiono S, Abiko M, Ogata S, Sato T, Tamura G . The correlation of the International Association for the Study of Lung Cancer (IASLC)/American Thoracic Society (ATS)/European Respiratory Society (ERS) classification with prognosis and EGFR mutation in lung adenocarcinoma. Ann Thorac Surg. 2014; 98(2):453-8. DOI: 10.1016/j.athoracsur.2014.04.108. View

20.

Rami-Porta R, Ball D, Crowley J, Giroux D, Jett J, Travis W . The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol. 2007; 2(7):593-602. DOI: 10.1097/JTO.0b013e31807a2f81. View